Skip to main content

Cognitive Decline clinical trials at UCSF

3 in progress, 1 open to eligible people

Cognitive decline means thinking and memory problems that come with aging. UCSF is recruiting for a study called "Brain Health Together: A Live-Streaming Group-Based Digital Program" to help older adults with cognitive decline. There are two other similar studies happening, but they are not looking for new participants.

Showing trials for
  • Brain Health Together: A Live-Streaming Group-Based Digital Program

    open to eligible people ages 55-85

    The purpose of this study is to develop and test a comprehensive Brain Health Together program for older adults living with cognitive decline.

    San Francisco, California

  • Computerized Cognitive Training in MS

    Sorry, in progress, not accepting new patients

    WHO: 40 participants with a confirmed diagnosis of Multiple Sclerosis (MS) able to engage in moderate physical activity. WHY: The purpose of this study is to evaluate two computerized brain training tools, which include light physical activity, to see if they can help improve cognitive functions, such as memory and attention, for patients with MS. WHAT: Complete a set of tests (physical and cognitive) at baseline, wear a Fitbit Flex device at home for the duration of the study, 3 supervised sessions for 4 weeks at UCSF, one visit for physical and cognitive tests at one week after the final supervised session, and one final visit 6 months after the final supervised session. WHERE: 20 participants at the UCSF Weill Institute for Neurosciences (675 Nelson Rising Lane, San Francisco, CA); 20 participants at Lausanne University Hospital (Rue du Bugnon 46, 1005 Lausanne, Switzerland)

    San Francisco, California and other locations

  • Correlation Between Montreal Cognitive Assessment and Voice Therapy Outcomes in the Aging Treatment- Seeking Population

    Sorry, accepting new patients by invitation only

    This study will investigate if the performance on the Montreal Cognitive Assessment (MoCA) is associated or predictive of the outcomes in voice, swallowing or upper airway therapy in the older laryngology treatment seeking patients. The relationship between the scores of MoCA and parameters in therapy will be analyzed. The outcomes of this study could potentially impact how investigators determine candidacy for therapy and develop patient treatment plans to meet their needs. This is a collaborative study with Emory Voice Center and the NYU Voice Center.

    San Francisco, California and other locations

Our lead scientists for Cognitive Decline research studies include .

Last updated: